Global private equity and venture capital news and research

Posts Tagged ‘pharmaceutical’

28 July 2016

Advent, CVC could halt THL’s inVentiv IPO after submitting bids

pills-530373_1920 Advent International and CVC Capital Partners are reportedly looking to grab private equity-owned pharma research business inVentiv before it launches an IPO.

5 July 2016

GHO eyes European eye care platform with pair of deals

eye-117043_1920 Healthcare investment specialist GHO Capital has agreed deals for Italian opthalmic company Visufarma and the European commercial arm of opthalmic business Nicox.

25 May 2016

Albion sells biotech business Haemostatix

blood-75302_1280 Albion Ventures and other investors have sold their stakes in biotech business Haemostatix.

16 May 2016

Apollo, Cinven consider bids for Teva UK, Ireland, Iceland drug portfolio

drug-1086712_1920 Private equity heavyweights Apollo Global Management and Cinven are said to be considering bids of up to $2bn for the UK, Ireland and Iceland drug portfolio of Teva Pharmaceutical.

20 April 2016

Seventure, Lundbeckfond back €14.5m Enterome Series C

tablets-700670_1920 Investors including Seventure and Lundbeckfond Ventures have backed a €14.5m Series C financing round for pharma developer Enterome Bioscience.

11 April 2016

Diversis buys majority stake in Caligor

health healthcare drugs pills medication medical Los Angeles-based private equity firm Diversis Capital has purchased Caligor, a provider of clinical trial supply and logistics services.

1 February 2016

Charterhouse cranks up process for potential Doc Generici sale

tablets-1001224_1920 London-headquartered private equity firm Charterhouse has reportedly contacted investment banks to run a sale of Italian drugmaker Doc Generici, which could see the company valued at up to €700m. Reports from Reuters at the start of December suggested the firm had brought in LEK Consulting to advise on options for the pharmaceutical company, which it[...]

14 December 2015

Carlyle, Hellman & Friedman-backed PPD could hit $8bn valuation through sale, IPO process

drug-1086712_1920 US buyout houses Carlyle and Hellman & Friedman are said to be prepping for a sale or IPO of research business Pharmaceutical Product Development which could value it at up to $8bn.

7 October 2015

European buyout majors eye €700m bidding for French pharma company Cooper

health-846863_1280 European private equity majors including Bridgepoint, BC Partners and Charterhouse Capital are reportedly among firm who could bid about €700m for French pharmaceutical company Cooper.

25 August 2015

Bain Capital backs sterile compound pharma manufacturer QuVa

pills-530372_1280 Bain Capital has bought a majority stake in new sterile compounding pharmacy services platform QuVa Pharma.

Page 1 of 2112345...1020...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016